102 related articles for article (PubMed ID: 4479613)
1. What shall we do with the HBAg carrier?
Br Med J; 1974 Nov; 4(5942):427-8. PubMed ID: 4479613
[No Abstract] [Full Text] [Related]
2. Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.
Briggs WA; Lazarus JM; Birtch AG; Hampers CL; Hager EB; Merrill JP
Arch Intern Med; 1973 Jul; 132(1):21-8. PubMed ID: 4577389
[No Abstract] [Full Text] [Related]
3. [Studies on juvenile chronic hepatitis].
Feist D
Fortschr Med; 1975 Sep; 93(25):1154-8. PubMed ID: 55374
[TBL] [Abstract][Full Text] [Related]
4. Control of hepatitis in a renal unit.
Fereres J; Maqueda S; Touchard A; D'Ocon MT
Proc Eur Dial Transplant Assoc; 1972; 9():618-22. PubMed ID: 4668944
[No Abstract] [Full Text] [Related]
5. [Blood donors with Australia antigen].
Farquet JJ; Guignard D; Portmann B; Lambert PH; Miescher PA
Schweiz Med Wochenschr; 1972 Nov; 102(44):1602-3. PubMed ID: 4645046
[No Abstract] [Full Text] [Related]
6. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.
Krugman S; Giles JP
N Engl J Med; 1973 Apr; 288(15):755-60. PubMed ID: 4688714
[No Abstract] [Full Text] [Related]
7. [Should chronic active viral hepatitis be treated with drugs or not?].
Schalm SW
Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
[No Abstract] [Full Text] [Related]
8. [Results of treatment of chronic hepatitis (author's transl)].
Thaler H; Szepesi T; Szepesi G
Dtsch Med Wochenschr; 1978 Nov; 103(45):1775-85. PubMed ID: 710287
[No Abstract] [Full Text] [Related]
9. Asymptomatic liver disease in hepatitis B antigen carriers.
Woolf IL; Boyes BE; Jones DM; Whittaker JS; Tapp E; MacSween RN; Renton PH; Stratton F; Dymock IW
J Clin Pathol; 1974 May; 27(5):348-52. PubMed ID: 4850682
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis and cirrhosis].
Thaler H
Dtsch Med Wochenschr; 1975 May; 100(18):1018-25. PubMed ID: 1132319
[No Abstract] [Full Text] [Related]
11. Treatment of chronic hepatitis.
Mistilis SP; Lam KC
Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
[No Abstract] [Full Text] [Related]
12. [Possibilities of immunotherapy in chronic liver diseases].
Kurdybaĭlo FV; Iakhontova OI; Efanov AN
Klin Med (Mosk); 1982 Sep; 60(9):49-53. PubMed ID: 7176488
[No Abstract] [Full Text] [Related]
13. [Transaminase activity in chronic hepatitis and liver cirrhosis].
Vido I; Wildhirt E
Munch Med Wochenschr; 1969 Feb; 111(6):277-81. PubMed ID: 5819088
[No Abstract] [Full Text] [Related]
14. Normotest in acute hepatitis and chronic liver disease.
Ockerman PA; Braconier JH; Eriksson O
Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
[No Abstract] [Full Text] [Related]
15. Hepatitis in the Auckland dialysis unit.
Bowie EA; Doak PB; North JD
N Z Med J; 1973 Feb; 77(489):75-80. PubMed ID: 4573132
[No Abstract] [Full Text] [Related]
16. Transmission of hepatitis and Australia antigenaemia within a liver unit.
Williams R
Proc R Soc Med; 1973 Aug; 66(8):799. PubMed ID: 4200333
[No Abstract] [Full Text] [Related]
17. [Indications and management of immunosuppressive therapy in chronic hepatitis].
Paumgartner G
Schweiz Med Wochenschr; 1973 Feb; 103(5):158-61. PubMed ID: 4685796
[No Abstract] [Full Text] [Related]
18. [Serum hepatitis in infants].
Braun OH; Münchenberg C; Michalke W; Becht T
Fortschr Med; 1971 Jul; 89(19):827-30. PubMed ID: 5154163
[No Abstract] [Full Text] [Related]
19. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
Tanno H; Fay O; Roldán L; Vorovioff J
Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
[TBL] [Abstract][Full Text] [Related]
20. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
